STC2 could form a histidine-rich glycoprotein/stanniocalcin-2 (HRG/STC2) complex with HRG to regulate murine glioma growth via modulation of anti-tumor immunity (Roche et al., 2018). The gene discussed is STC2; the disease is central nervous system cancer.